Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
XxxAccountant- we have over 600 in P3. This is completion of home trial P2. Please read the RNS it’s all in there.
I also read it as over 60s only receive 33% efficacy. The younger population may well bring this figure up. But they are not the people this vaccine is designed to protect.
Will there be supercar concierge parking? Once I’ve sold up that’s a pre requisite of my attendance anywhere.
Also Guilty. Been out 2 years but completed 12
100% it’s either caviar and mansions. Or stale bread and a cardboard box.
Hayd- you mean farons IV Inf that has failed in clinical trials to show any statistical difference.
I also feel in 12 months time this will be a £30bn drug. Evan just the COVID valuation if rumours are to be believed and the 500k treatments a month target are true will take this to £105 per share. People get transfixed on the actual price of the share, but forget we have a minuscule amount of issued shares compared to some others that have billions in issue. Any substantial cash offer reflects a bigger return per share for this very reason.
Ghia, I am exactly the same as you. I have sold every single share in my portfolio to buy SNG. Even this last week I’ve taken 10k more. I’m also praying I can get in tomorrow morning for 5k more before activ 2 news drops. Or any expected news that will make this rise. Holding a life changing amount of shares now that will allow me to retire at 34.
As I have said previously, I have invested absolutely 100% of all available funds into SNG. I’m just as keen as everyone else to start hearing about it being mentioned everywhere. But it cannot be done until we meet the primary end points of phase 3. If we look at it as a neutral data on our P2 hospital trial just isn’t big enough. We all ridiculed trump on here when he touted Plasma and Hydroxy. Data is what will drive this SP to the bullish broker target. Not a government in the world will not want to buy and stockpile SNG001 for the next 20 years if we successfully show safety and efficacy.
Matml.
The aerogen device can be sterilised and used on more that 1 patient. These devices are already the Number 1 nebuliser used in the developed world. Hundreds of thousands of these exist in hospitals all over UK and Europe.
DP, you obviously have no idea what your talking about. RM himself stated the biggest statistical difference was in patients on supplementary Oxygen. That is why P3 is solely focusing on that group
I actually think tomorrow will be a blue day, going by previous trends anyway
https://email.number10.gov.uk/
I feel we should email on mass, ask why the government are not supporting Synairgen. Over 600 deaths a day and SNG001 has shown it can prevent 79% of these people ever becoming seriously ill. It’s a national scandal.
You need to email consillium. PLEASE DO NOT EMAIL RM DIRECTLY. You will find he changes his email address if overwhelmed by PI's. That will then cut off our top notch researchers on this board from contact.
Punit, Still waiting for it to start
Punit 2-5 months after it commences.
Casting my mind back to when we started to see our II's selling. Do we think it was because they caught wind of the impending Vaccine? It would actually make a lot of sense, as most of them sold at a large loss. They obviously lost confidence in SNG and struggled to see where the treatment will fit into an ever shrinking market. I know its not just Covid but at the moment that is all we are aiming to treat, everything else has been put on hold and will require its own P3 trial before approval. I've been in since March so thankfully still over 100% profit (41p average). I'm guessing that situation is not the norm as people have bought and sold, top sliced, completely sold and partially rebought.
It was oversubscribed so maybe none of the II’s got allocated over the threshold. We have no idea how many applied for the placing.
How can it be subject to P3, if that's what they're using to pay for the P3 trial? The funds are with SNG now. They were required to pay for the shares upon admission to trading. We cant have an extra 50m shares admitted that haven't been paid for. The placing RNS states what they're spending the money on.